Gene · 3669
Papers4,236
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 4,236
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Atypical B cells consist of subsets with distinct functional profiles. | iScience | 2023 | 38098745 | PubTator, text mining | PubMed |
| Gene expression profile of HCT-8 cells following single or co-infections with Cryptosporidium parvum and bovine coronavirus. | Sci Rep | 2023 | 38092824 | PubTator, text mining | PubMed |
| Hematologic secondary malignancies among 102 Chinese patients with Waldenstrom's macroglobulinemia: a single-center case experience and literature review. | Front Oncol | 2023 | 38090491 | PubTator, text mining | PubMed |
| Host cellular factors involved in pseudorabies virus attachment and entry: a mini review. | Front Vet Sci | 2023 | 38089700 | PubTator, text mining | PubMed |
| A single-cell atlas of the peripheral immune response in patients with influenza A virus infection. | iScience | 2023 | 38089584 | PubTator, text mining | PubMed |
| The two-stage molecular scenery of SARS-CoV-2 infection with implications to disease severity: An in-silico quest. | Front Immunol | 2023 | 38077337 | PubTator, text mining | PubMed |
| Immune checkpoint status and exhaustion-related phenotypes of CD8+ T cells from the tumor-draining regional lymph nodes in breast cancer. | Cancer Med | 2023 | 38069525 | PubTator, text mining | PubMed |
| Quantitative proteomics defines mechanisms of antiviral defence and cell death during modified vaccinia Ankara infection. | Nat Commun | 2023 | 38065956 | PubTator, text mining | PubMed |
| Immune checkpoints are predominantly co-expressed by clonally expanded CD4+FoxP3+ intratumoral T-cells in primary human cancers. | J Exp Clin Cancer Res | 2023 | 38057799 | PubTator, text mining | PubMed |
| A natural product YSK-A blocks SARS-CoV-2 propagation by targeting multiple host genes. | Sci Rep | 2023 | 38057373 | PubTator, text mining | PubMed |
| [The value of CD200 in differential diagnosis of classic hairy cell leukemia and variant hairy cell leukemia]. | Zhonghua Xue Ye Xue Za Zhi | 2023 | 38049324 | PubTator, text mining | PubMed |
| Non-canonical STING-PERK pathway dependent epigenetic regulation of vascular endothelial dysfunction via integrating IRF3 and NF-κB in inflammatory response. | Acta Pharm Sin B | 2023 | 38045042 | PubTator, text mining | PubMed |
| The prognostic significance of tumor-immune microenvironment in ascites of patients with high-grade serous carcinoma. | Radiol Oncol | 2023 | 38038414 | PubTator, text mining | PubMed |
| RNA-sequencing based first choice of treatment and determination of risk in multiple myeloma. | Front Immunol | 2023 | 38035078 | PubTator, text mining | PubMed |
| Changes in immune cell populations following KappaMab, lenalidomide and low-dose dexamethasone treatment in multiple myeloma. | Clin Transl Immunology | 2023 | 38034081 | PubTator, text mining | PubMed |
| Revolutionizing orofacial pain management: the promising potential of stem cell therapy. | Front Pain Res (Lausanne) | 2023 | 38028430 | PubTator, text mining | PubMed |
Long term follow-up of refractory/relapsed hairy cell leukaemia patients treated with low-dose vemurafenib between 2013 and 2022 at the Department of Internal Medicine and Oncology, Semmelweis University. | Pathol Oncol Res | 2023 | 38025907 | PubTator, text mining | PubMed |
| Vpr attenuates antiviral immune responses and is critical for full pathogenicity of SIVmac239 in rhesus macaques. | iScience | 2023 | 38025783 | PubTator, text mining | PubMed |
| Primary cutaneous T-follicular helper lymphoma. | EJHaem | 2023 | 38024630 | PubTator, text mining | PubMed |
| Chronic granulomatous disease in the United Arab Emirates: clinical and molecular characteristics in a single center. | Front Immunol | 2023 | 38022624 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3669/papers?page=17